Trial site
Athens Medical Center S.A.
- 17running trials
- 15closed trials
The trials here
What the 32 trials at this site are about, from their registry records.
- Conditions
- COPD10 trials
- Type 2 diabetes9 trials
- Obesity7 trials
- Asthma5 trials
- Chronic kidney disease5 trials
- Type 1 diabetes2 trials
- Bronchiectasis1 trial
- Heart failure1 trial
- Stroke1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 324 trials
- Phase 27 trials
- Phase 41 trial
- Status
- Completed15 trials
- Recruiting12 trials
- Active, not recruiting5 trials
- Lead sponsor
- AstraZeneca7 trials
- Novo Nordisk A/S5 trials
- Eli Lilly and Company3 trials
- Sanofi3 trials
- Ascletis Pharma (China) Co. Ltd.2 trials
- and 10 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD3 recruiting
- Type 2 diabetes3 recruiting
- Asthma2 recruiting
- Obesity2 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
Closed trials
Active, not recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Completed
Completed
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Completed
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026